Data Mining in Large Frequency Tables With Ontology, with an Application to the Vaccine Adverse Event Reporting System
Bangyao Zhao, Lili Zhao

TL;DR
This paper introduces zGPS.AO, a novel statistical method leveraging AE ontology and zero-inflated models to improve vaccine adverse event signal detection, providing more accurate and meaningful risk estimates at the group level.
Contribution
The paper develops a new zero-inflated negative binomial regression model incorporating AE ontology, enhancing the accuracy and stability of adverse event risk estimation in vaccine safety analysis.
Findings
Model demonstrates low bias and variance in simulations.
Produces meaningful, coherent results on VAERS data.
Implemented as an R package with interactive visualization.
Abstract
Vaccine safety is a concerning problem of the public, and many signal detecting methods have been developed to identify relative risks between vaccines and adverse events (AEs). Those methods usually focus on individual AEs, where the randomness of data is high. The results often turn out to be inaccurate and lack of clinical meaning. The AE ontology contains information about biological similarity of AEs. Based on this, we extend the concept of relative risks (RRs) to AE group level, which allows the possibility of more accurate and meaningful estimation by utilizing data from the whole group. In this paper, we propose the method zGPS.AO (Zero Inflated Gamma Poisson Shrinker with AE ontology) based on the zero inflated negative binomial distribution. This model has two purples: a regression model estimating group level RRs, and a empirical bayes framework to evaluate AE level RRs. The…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacovigilance and Adverse Drug Reactions · Statistical Methods in Clinical Trials · Computational Drug Discovery Methods
